From: A sui generis QA approach using RoBERTa for adverse drug event identification
Methods
P
R
F1
CNN + Global features [22]
64.00
62.90
63.40
BiLSTM + SDP [10]
67.50
75.80
71.40
SpERT [15]
77.77
79.96
78.84
Our model (end-to-end)
88.37
84.44
86.36
